Next Steps in Heart Failure: The Changing Paradigms in Therapy to the Unmet Needs
Published: 26 October 2022
5m 30sPart 1 | Session 1 Chapter 1 - Video Duration: 5m 30s Javed Butler, Clyde W Yancy, Faiez Zannad, Christiane Angermann
10m 2sPart 2 | Session 1 Chapter 2.1 - Video Duration: 9m 58s Christiane Angermann
8m 42sPart 3 | Session 1 Chapter 2.2 - Video Duration: 8m 42s Javed Butler, Clyde W Yancy, Faiez Zannad, Christiane Angermann
12m 54sPart 4 | Session 1 Chapter 3 - Video Duration: 12m 54s Faiez Zannad
10m 50sPart 5 | Session 1 Chapter 4 - Video Duration: 10m 50s Clyde W Yancy
During this broadcast, "Next Steps in Heart Failure: The Changing Paradigms in Therapy to the Unmet Needs", Radcliffe Medical Education brings together a globally-renowned European and American faculty to participate in a roundtable discussion. The aim: to provide both a reflection on the HF landscape following published data at congress and to examine what future developments can be expected at forthcoming events via lively discussion and data presentations.
Dr Javed Butler (University of Mississippi Medical Center, US) leads proceedings, and is joined by Dr Clyde Yancy (Northwestern University Feinberg School of Medicine, US), Prof Faiez Zannad (Academic Hospital (CHU), Nancy, FR), and Prof Christiane Angermann (University Hospital of Würzburg, Würzburg, DE) for an insightful presentation and a discussion.
Upon participation in the roundtable discussion physicians will be able to:
- Recall the utility of EF in heart failure treatment, patient selection and treatment response
- Identify alternative measures to EF for the purposes HF severity and therapeutic efficacy
- Incorporate quality of life measures for assessing therapeutic efficacy in HF
- Recall outcomes from heart failure trials from recent congress and publications and their impact on practice
This programme is intended to educate:
- Global Heart Failure Physicians
- General Cardiologists
More from this programme
How Is the Landscape of HF Changing?
A Changing Paradigm in the Progression of HF Therapy Initiation
An ESC 2022 Update: Relevant New Medical Data
Applying the Guidelines in Clinical Practice
Professor of Medicine
Dr Javed Butler is President, Baylor Scott and White Research Institute, Senior Vice President for the Baylor Scott and White Health and Professor of Medicine at the University of Mississippi, US. He is board certified in cardiovascular medicine and advanced heart failure and transplant medicine. His research interests focus on clinical trials in patients with heart failure.
He serves on several national committees for the American College of Cardiology, American Heart Association, National Institutes of Health, and the Heart Failure Society of America. He is the recipient of the Simon Dack Award by the American College of Cardiology as well as the Time, Feeling, and Focus Award by the American Heart Association.
Prof Butler has authored more than 900 peer-reviewed publications. He serves on the editorial board of several peer reviewed cardiovascular journals and has been cited numerous times in America’s Best Doctors list.
Clyde W Yancy
Chief of Cardiology
Dr Clyde W Yancy, is Vice-Dean of Diversity & Inclusion, Northwestern University, Feinberg School of Medicine in Chicago, US. He concomitantly serves as Chief of Cardiology at Northwestern University, Feinberg School of Medicine, and Associate Director of the Bluhm Cardiovascular Institute at Northwestern Memorial Hospital. He holds the Magerstadt Endowed Professor of Medicine Chair and also holds an appointment as Professor of Medical Social Sciences.
Dr Yancy’s research interests are heart failure, clinical guideline generation, outcomes sciences, personalized medicine, and health care disparities. He is extensively published with well over 600 peer-reviewed publications, an H-index of > 100 and annual recognition as one of the most highly cited scientific authors worldwide. Dr Yancy is Deputy Editor, JAMA Cardiology, and Senior Section Editor (Heart Failure), Journal of the American College of Cardiology (JACC). He serves on the editorial boards for…
Professor of Therapeutics and Cardiology, Head of CIC
Dr Faiez Zannad is Professor of Therapeutics & Cardiology and Head of the Division of Heart Failure, Hypertension and Preventive Cardiology for the department of Cardiovascular Disease of the Academic Hospital (CHU) in Nancy and the Director of the Clinical Investigation Centre (Inserm-CHU).
Dr Zannad is currently the Chairman of the ESC Working group on Pharmacology and Drug Therapy as well as a Boardmember of the ESC Heart Failure Association. He is Past-President of the French Society of Hypertension.
Dr Zannad is Co-Editor-in-Chief for Fundamental and Clinical Pharmacology, the official journal of the European Pharmacology Societies Federation (EUPHAR). He chairs and organises annual international meetings on CardioVascular Clinical Trials (CVCT) and on Biomarkers in Heart Failure.
Prof Christiane E. Angermann is trained in Medicine/Cardiology in Munich. At the Munich Univ. Hospital, she established a Multidisciplinary Program for Advanced Heart Failure (HF)/HTX. In 2001, she became Professor of Medicine/Cardiology at Würzburg University, heading the Cardiology Division, Department of Medicine II. She is one of the 5 founders of the Comprehensive Heart Failure Center Würzburg (CHFC), became CHFC Director of Clinical Research in 2010, and is currently Senior CHFC Professor of Clinical Research in Cardiology/HF.
Her main interests are healthcare research, eHealth and telemedicine, multi-morbidity, heart-mind-body interactions and prevention of HF.
Prof Angermann is/was an EC/SC member and/or National Leader of multiple clinical trials, (e.g., REPORT-HF, MEMS-HF, PASSPORT-HF, EMPULSE), and acts as reviewer, Ed. Board member or Editor-in-Chief (Current Heart Failure Reports) for many journals.